GlassScriptPhysician profile
John S Lignore
NPI 1851513253
$2,257.68
in general payments reported to CMS, 2019-2025
10 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.84 · 2022: $128 · 2023: $968 · 2024: $974 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.72 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $484.30 | 2023-2024 | Arista Ah Flexitip |
| Kerecis Limited | $435.17 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $382.58 | 2022-2025 | Citrefix, Gamma, Pangea |
| Heron Therapeutics, INC. | $307.67 | 2023-2024 | Zynrelef |
| Smith+Nephew, INC. | $189.19 | 2022-2023 | Pico, Renasys Go V2 Home |
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Molnlycke Health Care US, LLC | $106.09 | 2021-2024 | Mepilex Border Sacrum, Mepilex Border Flex, Mepilex Lite |
| My01 INC. | $90.25 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Ethicon US, LLC | $66.30 | 2022-2025 | Evarrest, Ethicon, Vistaseal |
| Solventum Corporation | $59.12 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lignore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.